AU1652601A - New combination comprising a beta2-adrenoreceptor agonist and a leukotriene receptor antagonist - Google Patents

New combination comprising a beta2-adrenoreceptor agonist and a leukotriene receptor antagonist

Info

Publication number: AU1652601A
Authority: AU; Australia
Prior art keywords: beta2; receptor antagonist; new combination; leukotriene receptor; adrenoreceptor agonist
Prior art date: 1999-11-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU16526/01A

Inventor

Jan Trofast

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

AstraZeneca AB

Original Assignee

AstraZeneca AB

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-03

Filing date

2000-10-27

Publication date

2001-05-14

2000-10-27 Application filed by AstraZeneca AB filed Critical AstraZeneca AB

2001-05-14 Publication of AU1652601A publication Critical patent/AU1652601A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Otolaryngology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

AU16526/01A 1999-11-03 2000-10-27 New combination comprising a beta2-adrenoreceptor agonist and a leukotriene receptor antagonist Abandoned AU1652601A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
SE9903995A SE9903995D0 (en)	1999-11-03	1999-11-03	New combination
SE9903995		1999-11-03
PCT/SE2000/002116 WO2001032166A1 (en)	1999-11-03	2000-10-27	NEW COMBINATION COMPRISING A β2-ADRENORECEPTOR AGONIST AND A LEUKOTRIENE RECEPTOR ANTAGONIST

Publications (1)

Publication Number	Publication Date
AU1652601A true AU1652601A (en)	2001-05-14

Family

ID=20417605

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU16526/01A Abandoned AU1652601A (en)	1999-11-03	2000-10-27	New combination comprising a beta2-adrenoreceptor agonist and a leukotriene receptor antagonist
AU13214/01A Abandoned AU1321401A (en)	1999-11-03	2000-10-27	New combination comprising a beta 2 (beta)2 adreno receptor agonist and a leukotriene receptor antagonist

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AU13214/01A Abandoned AU1321401A (en)	1999-11-03	2000-10-27	New combination comprising a beta 2 (beta)2 adreno receptor agonist and a leukotriene receptor antagonist

Country Status (13)

Country	Link
EP (1)	EP1242065A1 (en)
JP (1)	JP2003513037A (en)
KR (1)	KR20020050254A (en)
CN (1)	CN1387431A (en)
AU (2)	AU1652601A (en)
BR (1)	BR0015172A (en)
CA (1)	CA2388657A1 (en)
IL (1)	IL149365A0 (en)
MX (1)	MXPA02004334A (en)
NO (1)	NO20022103L (en)
SE (1)	SE9903995D0 (en)
WO (2)	WO2001032166A1 (en)
ZA (1)	ZA200203178B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6667344B2 (en)	2001-04-17	2003-12-23	Dey, L.P.	Bronchodilating compositions and methods
US20030055026A1 (en)	2001-04-17	2003-03-20	Dey L.P.	Formoterol/steroid bronchodilating compositions and methods of use thereof
PE20050130A1 (en) *	2002-08-09	2005-03-29	Novartis Ag	ORGANIC COMPOUNDS
GB0312148D0 (en)	2003-05-28	2003-07-02	Aventis Pharma Ltd	Stabilized pharmaceutical products
GB0315889D0 (en)	2003-07-08	2003-08-13	Aventis Pharma Ltd	Stable pharmaceutical products
TWI359675B (en)	2003-07-10	2012-03-11	Dey L P	Bronchodilating β-agonist compositions
JP2007531743A (en) *	2004-04-05	2007-11-08	セプラコアインコーポレーテッド	(R, R) -formoterol in combination with other drugs
ES2245612B1 (en) *	2004-06-29	2007-08-16	Universidad De Barcelona	NEW THERAPEUTIC USE OF FORMOTEROL.
SI1863476T1 (en) *	2005-03-16	2016-05-31	Meda Pharma Gmbh & Co. Kg	The combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
EP2718267B1 (en)	2011-06-06	2016-08-10	Chiesi Farmaceutici S.p.A.	Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
AR093796A1 (en) *	2012-12-05	2015-06-24	Chiesi Farm Spa	ALCOHOL DERIVATIVES 1-PHENYL-2-PIRIDINIL ALQUILICO AS INHIBITORS OF PHOSPHODIESTERASE
JP5846185B2 (en)	2013-11-21	2016-01-20	大日本印刷株式会社	Through electrode substrate and semiconductor device using the through electrode substrate
PT109030B (en) *	2015-12-15	2019-09-25	Hovione Farmaciência, S.A.	PREPARATION OF ZAFIRLUCAST INHALABLE PARTICULES

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9604752D0 (en) *	1996-12-20	1996-12-20	Astra Ab	Formulation and use
ATE317224T1 (en) *	1997-03-13	2006-02-15	Merck & Co Inc	QUINOLINE-LEUKOTRIEN ANTAGONISTS
SE9704644D0 (en) *	1997-12-12	1997-12-12	Astra Ab	New use

1999
- 1999-11-03 SE SE9903995A patent/SE9903995D0/en unknown
2000
- 2000-10-27 CA CA002388657A patent/CA2388657A1/en not_active Abandoned
- 2000-10-27 AU AU16526/01A patent/AU1652601A/en not_active Abandoned
- 2000-10-27 BR BR0015172-6A patent/BR0015172A/en not_active Application Discontinuation
- 2000-10-27 JP JP2001534368A patent/JP2003513037A/en active Pending
- 2000-10-27 WO PCT/SE2000/002116 patent/WO2001032166A1/en not_active Ceased
- 2000-10-27 IL IL14936500A patent/IL149365A0/en unknown
- 2000-10-27 EP EP00975117A patent/EP1242065A1/en not_active Withdrawn
- 2000-10-27 KR KR1020027005683A patent/KR20020050254A/en not_active Withdrawn
- 2000-10-27 CN CN00815363A patent/CN1387431A/en active Pending
- 2000-10-27 MX MXPA02004334A patent/MXPA02004334A/en unknown
- 2000-10-27 AU AU13214/01A patent/AU1321401A/en not_active Abandoned
- 2000-10-27 WO PCT/SE2000/002115 patent/WO2001032163A1/en not_active Ceased
2002
- 2002-04-22 ZA ZA200203178A patent/ZA200203178B/en unknown
- 2002-05-02 NO NO20022103A patent/NO20022103L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2001032166A1 (en)	2001-05-10
EP1242065A1 (en)	2002-09-25
AU1321401A (en)	2001-05-14
NO20022103D0 (en)	2002-05-02
CN1387431A (en)	2002-12-25
WO2001032163A1 (en)	2001-05-10
JP2003513037A (en)	2003-04-08
BR0015172A (en)	2002-06-18
IL149365A0 (en)	2002-11-10
ZA200203178B (en)	2003-07-22
KR20020050254A (en)	2002-06-26
CA2388657A1 (en)	2001-05-10
NO20022103L (en)	2002-05-02
MXPA02004334A (en)	2002-11-07
SE9903995D0 (en)	1999-11-03

Publication	Publication Date	Title
AU4336899A (en)	1999-12-30	Novel leukotriene receptor antagonists and their uses
AU3080499A (en)	1999-09-27	Analgesic combination comprising nmda receptor antagonists and narcotic analgesics
IL137990A0 (en)	2001-10-31	A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof
AU4698299A (en)	2000-01-17	5-HT7 receptor antagonists
AU8689798A (en)	1999-02-22	Integrin receptor antagonists
AU775774C (en)	2005-05-19	Peroxisome proliferator-activated receptor agonist
AU1652601A (en)	2001-05-14	New combination comprising a beta2-adrenoreceptor agonist and a leukotriene receptor antagonist
AU2001225663A1 (en)	2001-12-24	A composition comprising a combination of receptor agonists and antagonists
AUPP380498A0 (en)	1998-06-25	Egf receptor agonists and antagonists
AU2001290772A1 (en)	2002-03-26	Alpha v integrin receptor antagonists
AU2371400A (en)	2000-07-03	Vitronectin receptor antagonist pharmaceuticals
IL138576A0 (en)	2001-10-31	A novel interleukin-1 receptor antagonist and uses thereof
AU2441801A (en)	2001-07-03	Urotensin-ii receptor antagonists
AU6990000A (en)	2001-03-05	Novel integrin receptor antagonists
AU1100300A (en)	2000-04-26	Piperidyloxadiazoles as dopamine receptor antagonists
AU5861900A (en)	2001-01-02	Receptor agonists and antagonists
AU6230698A (en)	1998-09-18	Dopamine d4 receptor antagonist
IL146146A0 (en)	2002-07-25	Integrin receptor antagonists
IL137428A0 (en)	2001-07-24	Estrogen agonists and antagonists for multiple indications
AU2574801A (en)	2001-07-03	Selective iGLUR5 receptor antagonists
AU6051200A (en)	2001-01-02	Il-8 receptor antagonists
AU6826498A (en)	1998-10-12	Endotholin receptor antagonists
AU5572500A (en)	2001-01-22	Vegf receptor antagonists
AU2079501A (en)	2001-06-18	Human cysteinyl leukotriene receptor
AU5748300A (en)	2001-01-02	Il-8 receptor antagonists

Legal Events

Date	Code	Title	Description
2002-06-27	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase